Q4 2024 Holdings
Filed 2025-02-14 | 63 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $227.2M | 17,791,486 | 8.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $196.1M | 6,419,566 | 7.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $167.0M | 2,000,000 | 6.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $148.6M | 6,000,000 | 5.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $136.4M | 4,274,921 | 5.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $125.0M | 3,460,756 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $117.6M | 2,500,000 | 4.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $109.6M | 12,836,282 | 4.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $86.7M | 4,522,741 | 3.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $78.7M | 5,972,257 | 2.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $75.9M | 2,800,000 | 2.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $67.6M | 1,933,928 | 2.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $56.5M | 3,000,000 | 2.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $55.6M | 3,018,935 | 2.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $50.7M | 6,478,249 | 1.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $49.9M | 1,450,000 | 1.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $47.1M | 2,000,000 | 1.8% |
| Septerna Inc(SEPN) | COM | 81734D104 | $43.8M | 1,912,929 | 1.6% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $42.4M | 4,000,000 | 1.6% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $41.7M | 2,000,000 | 1.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $41.5M | 1,490,000 | 1.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $39.5M | 850,000 | 1.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $38.9M | 1,540,132 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $38.6M | 1,000,000 | 1.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $35.9M | 649,042 | 1.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $34.8M | 2,000,000 | 1.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $33.4M | 14,218,903 | 1.2% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $33.3M | 874,614 | 1.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $30.9M | 5,576,558 | 1.2% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $30.3M | 4,557,575 | 1.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $27.5M | 653,513 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $26.2M | 3,579,209 | 1.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $22.6M | 1,350,000 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $22.5M | 819,162 | 0.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $21.5M | 780,778 | 0.8% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $20.1M | 3,442,833 | 0.7% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $19.6M | 2,816,594 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $19.0M | 710,421 | 0.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $17.9M | 1,276,081 | 0.7% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $16.4M | 1,000,000 | 0.6% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $16.1M | 2,000,000 | 0.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $15.3M | 519,376 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $14.5M | 750,000 | 0.5% |
| Geron Corp(GERN) | COM | 374163103 | $14.2M | 4,011,287 | 0.5% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $13.5M | 1,529,987 | 0.5% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $12.6M | 1,189,800 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $11.5M | 500,000 | 0.4% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $9.7M | 244,110 | 0.4% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $9.5M | 6,011,380 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $8.2M | 3,283,783 | 0.3% |